A Hydrazine–Hydrazone Adamantine Compound Shows Antimycobacterial Activity and Is a Probable Inhibitor of MmpL3

Tuberculosis remains an important cause of morbidity and mortality throughout the world. Notably, an important number of multi drug resistant cases is an increasing concern. This problem points to an urgent need for novel compounds with antimycobacterial properties and to improve existing therapies....

Descripción completa

Detalles Bibliográficos
Autores principales: Briffotaux, Julien, Xu, Yanji, Huang, Wei, Hui, Zhen, Wang, Xiao, Gicquel, Brigitte, Liu, Shengyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610904/
https://www.ncbi.nlm.nih.gov/pubmed/36296721
http://dx.doi.org/10.3390/molecules27207130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610904/
https://www.ncbi.nlm.nih.gov/pubmed/36296721
http://dx.doi.org/10.3390/molecules27207130

Ejemplares similares